Enanta Pharmaceuticals
ENTA
#8720
Rank
โ‚น20.59 B
Marketcap
โ‚น706.15
Share price
-4.51%
Change (1 day)
-34.21%
Change (1 year)

EPS for Enanta Pharmaceuticals (ENTA)

EPS in 2026 (TTM): -โ‚น220.66

According to Enanta Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น223.33. In 2025 the company made an earnings per share (EPS) of -โ‚น296.54 an increase over its 2024 EPS that were of -โ‚น458.72.

EPS history for Enanta Pharmaceuticals from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น220.66-25.59%
2025-โ‚น296.54-35.35%
2024-โ‚น458.72
2021-โ‚น461.5072.92%
2020-โ‚น266.89-267.44%
2019โ‚น159.39-61.35%
2018โ‚น412.38147.22%
2017โ‚น166.81-460%
2016-โ‚น46.33-114.88%
2015โ‚น311.37-23.81%
2014โ‚น408.67-244.12%
2013-โ‚น283.57

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น619.02-377.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น486.52-317.84%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
โ‚น542.27-342.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚น1,452-750.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น92.03-141.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น418.87-287.55%๐Ÿ‡บ๐Ÿ‡ธ USA